Kyungdong Multi Vita Injection

Adult administration

Dissolve 5 mL of this drug in injection-grade distilled water with a gentle shake, then mix with 500-1,000 mL of intravenous glucose solution, saline injection, or similar infusion solution for administration via intravenous drip once daily within 5 minutes.

Child administration

For children over 11 years: Dissolve 5 mL of this drug in injection-grade distilled water with a gentle shake, then mix with 500-1,000 mL of intravenous glucose solution, saline injection, or similar infusion solution within 5 minutes for administration.

Caution is advised when administering this drug to women in the first 3 months of pregnancy or to women who may become pregnant, as administering more than 5,000 IU of Vitamin A may increase the risk of congenital malformations. Patients with an allergic reaction to any ingredient in this medication or patients with hemophilia should not use this drug. Patients with hypercalcemia may experience further elevation of calcium levels due to the Vitamin D in this drug, so blood and urine tests should be conducted to monitor the condition and the medication should be discontinued if necessary. Patients with impaired kidney function should also be cautious as excessive Vitamin D intake could worsen kidney function. It should be administered to children over 11 years of age with caution, and those with asthma or a predisposition to skin allergies, as well as patients who have experienced hypersensitivity reactions to medications, should also be closely monitored. In cases of overdose, hypersensitivity reactions to Vitamins A and D may occur, and in severe cases, serious allergic symptoms such as shock or anaphylaxis can arise, necessitating immediate cessation of use and appropriate medical treatment. It is important to monitor Vitamin A and D levels if used for a prolonged period. This drug may interact with certain medications; therefore, patients taking other medications must consult an expert. Pregnant or breastfeeding women should adhere to appropriate dosing to avoid the risk of side effects from vitamin overdose. Use in children under the age of 11 is not recommended as safety and efficacy have not been sufficiently established. Elderly patients may have diminished bodily functions, thus dosage should be adjusted accordingly and used with caution. This drug may affect some clinical test results, and patients should inform the tester of its use prior to testing. When using this drug, it should be administered immediately after opening, and any remaining medication should be discarded. Since some components are light-sensitive, it is advisable to store it away from light. Do not inject the concentrate without dilution, and when mixed, it should be used within 8 hours for safety. It should be stored out of the reach of children, refrigerated, and kept away from freezing. Transferring the medication to another container can lead to misuse and degradation in quality; therefore, it must be stored in its original container.

Serious side effects

• Shortness of breath
• shock
• anaphylactoid symptoms

Mild side effects

• Itching
• sweating
• facial flushing
• low blood pressure
• altered consciousness
• nausea
• chest discomfort
• dizziness
• fainting

This medication should be stored in a sealed container to prevent exposure to air, and it is safe to keep it at a temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way will help maintain the medication's effectiveness for a longer time.

Appearance

Lyophilized injection in a brown vial containing yellow lumps

Package unit

10 vials / case